Keyphrases
Antipsychotics
100%
First-episode Psychosis
100%
Nave
60%
Metabolic Parameters
50%
Odds Ratio
50%
Confidence Interval
50%
Quality of Life
50%
Greater Copenhagen
50%
Population-based Study
50%
Psychopathology
50%
Severe Mental Illness
50%
Dyslipidemia
50%
Glycocalyx Shedding
50%
Shedding Patterns
50%
Glycocalyx
50%
Healthy Controls
26%
Pharmacotherapy
20%
Metabolic Syndrome Prevalence
20%
Lipid-lowering
20%
Psychopathological
20%
Symptom Severity
16%
Blood-brain Barrier
16%
Psychotic Disorders
11%
Machine Learning Models
11%
Metabolic Syndrome
10%
Positive Symptoms
10%
Metabolic Side Effects
10%
High Cardiovascular Risk
10%
Predictive Value
10%
Physical Health
10%
Antipsychotic Monotherapy
10%
Negative Symptoms
10%
Predictors of Quality of Life
10%
Early Psychosis
10%
Waist Circumference
10%
Psychological Health
10%
Lipid Biomarkers
10%
Multivariate Linear Regression
10%
Body Mass Index
10%
Class Degree
6%
Antipsychotic Adherence
6%
Antipsychotic Switch
6%
Endothelial Glycocalyx
5%
Protective Layer
5%
Marker Detection
5%
Biomarkers for Early Diagnosis
5%
Peripheral Blood
5%
Blood Samples
5%
Classification Accuracy
5%
Inflammatory Markers
5%
Pharmacology, Toxicology and Pharmaceutical Science
Antipsychotic
100%
Psychosis
50%
Blood-Brain Barrier
50%
Symptom
37%
Biological Marker
12%
Immunoglobulin
12%
Nervous System Inflammation
12%
Medicine and Dentistry
Odds Ratio
50%
Dyslipidemia
50%
Severe Mental Illness
50%
Drug Therapy
20%
Cardiovascular Risk
15%
Cardiovascular Disease
5%
Acute Coronary Syndrome
5%
Transient Ischemic Attack
5%
Schizophrenia Spectrum Disorder
5%
General Practitioner
5%
Hypolipidemic Agent
5%
Awareness
5%
Bipolar Disorder
5%
Brain Ischemia
5%
Secondary Prevention
5%
Logistic Regression Analysis
5%
